Skip to main content
Fig. 8 | Cancer Nanotechnology

Fig. 8

From: Development of highly efficient niosomal systems for co-delivery of drugs and genes to treat breast cancer in vitro and in vivo

Fig. 8

a Effect of Cur and miRNA formulations on the bodyweight at every 3-day intervals, respectively. b, c Tumor size (cm3) of different mice groups after 21 days of receiving the medicine. All groups displayed a major decrease (P < 0.05) in the tumor volumes than the control group after 14 and 21 days. d Tumor inhibition rate

Back to article page